News
Advertisement
Company News Release
Advertisement
Applied Clinical Trials
Lisa Henderson discusses the debate around aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.
Advertisement
Company News Release
Company News Release
Advertisement
Applied Clinical Trials
Medidata Minute Episode 2: Recorded live at the Forbes Health Care Summit, Harlan Krumholz, Professor of Medicine Epidemiology & Public Health, Yale University and Andy Slavitt, group executive vice president at Optum discuss regulation in healthcare
Applied Clinical Trials
Applied Clinical Trials
Multimedia: Editorial Director Lisa Henderson talks with Steve Powell, PRA Executive VP Clinical Informatics and Late Phase Services about PRA's Informatics Expansion at its new Swansea, Wales office
Applied Clinical Trials
Video Blog-- Strategic Outsourcing: A Concept for Debate? Are strategic partnerships in a too-early-to-tell stage? A passing fad or here to stay
Applied Clinical Trials
Applied Clinical Trials Editorial talks with CluePoints' Founder Marc Buyse about the history of CluePoints as well as the role of biostatistics in clinical trials
Company News Release
Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
Applied Clinical Trials
Risk-based monitoring was in Trans-Celerate BioPharma's sights since the pharmaceutical company collaborative was announced in September 2012.
Applied Clinical Trials
Food and Drug Administration officials are busy implementing its provisions that offer new approaches to clinical trial design and application review.
Applied Clinical Trials
Treatment networks and network meta-analysis of randomized trials can boost understanding of how much evidence is available for each treatment and treatment comparison.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps
3
A Shot in the Arm to Traditional Vaccine Trial Strategy
4
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
5